AMCA
Arthur M. Cohen & Associates’s Bristol-Myers Squibb BMY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $278K | Buy |
6,010
+2,000
| +50% | +$92.6K | 0.05% | 113 |
|
|
2025
Q1 | $245K | Hold |
4,010
| – | – | 0.05% | 115 |
|
|
2024
Q4 | $227K | Hold |
4,010
| – | – | 0.04% | 128 |
|
|
2024
Q3 | $212K | Buy |
+4,010
| New | +$212K | 0.04% | 134 |
|
|
2024
Q2 | – | Sell |
-3,990
| Closed | -$216K | – | 141 |
|
|
2024
Q1 | $216K | Buy |
+3,990
| New | +$216K | 0.05% | 126 |
|
|
2019
Q4 | – | Sell |
-3,990
| Closed | -$202 | – | 126 |
|
|
2019
Q3 | $202 | Buy |
+3,990
| New | +$202 | 0.06% | 121 |
|
|
2019
Q2 | – | Sell |
-8,745
| Closed | -$417K | – | 118 |
|
|
2019
Q1 | $417K | Sell |
8,745
-39,191
| -82% | -$1.87M | 0.15% | 79 |
|
|
2018
Q4 | $2.98K | Hold |
47,936
| – | – | 0.95% | 21 |
|
|
2018
Q3 | $2.98K | Sell |
47,936
-3,531
| -7% | -$219 | 0.91% | 21 |
|
|
2018
Q2 | $2.85M | Buy |
51,467
+140
| +0.3% | +$7.75K | 1.08% | 18 |
|
|
2018
Q1 | $3.15M | Buy |
51,327
+21,273
| +71% | +$1.3M | 1.19% | 18 |
|
|
2017
Q4 | $1.56K | Buy |
+30,054
| New | +$1.56K | 0.43% | 27 |
|
|
2017
Q2 | $3.22M | Sell |
57,197
-26,437
| -32% | -$1.49M | 1.26% | 23 |
|
|
2017
Q1 | $3.07M | Buy |
83,634
+28,380
| +51% | +$1.04M | 1.37% | 23 |
|
|
2016
Q4 | $3.18M | Buy |
+55,254
| New | +$3.18M | 1.68% | 15 |
|
|
2014
Q3 | $3.6M | Buy |
+56,397
| New | +$3.6M | 1.67% | 17 |
|